Literature DB >> 11029641

Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain.

M E Keck1, I Sillaber, K Ebner, T Welt, N Toschi, S T Kaehler, N Singewald, A Philippu, G K Elbel, C T Wotjak, F Holsboer, R Landgraf, M Engelmann.   

Abstract

Using intracerebral microdialysis in urethane-anaesthetized adult male Wistar rats, we monitored the effects of acute repetitive transcranial magnetic stimulation (rTMS; 20 trains of 20 Hz, 2.5 s) on the intrahypothalamic release of arginine vasopressin (AVP) and selected amino acids (glutamate, glutamine, aspartate, serine, arginine, taurine, gamma-aminobutyric acid) and the intrahippocampal release of monoamines (dopamine, noradrenaline, serotonin) and their metabolites (homovanillic acid, 3,4-dihydroxyphenylacetic acid, 5-hydroxyindoleacetic acid). The stimulation parameters were adjusted according to the results of accurate computer reconstructions of the current density distributions induced by rTMS in the rat and human brains, ensuring similar stimulation patterns in both cases. There was a continuous reduction in AVP release of up to 50% within the hypothalamic paraventricular nucleus in response to rTMS. In contrast, the release of taurine, aspartate and serine was selectively stimulated within this nucleus by rTMS. Furthermore, in the dorsal hippocampus the extracellular concentration of dopamine was elevated in response to rTMS. Taken together, these data provide the first in vivo evidence that acute rTMS of frontal brain regions has a differentiated modulatory effect on selected neurotransmitter/neuromodulator systems in distinct brain areas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029641     DOI: 10.1046/j.1460-9568.2000.00243.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  25 in total

Review 1.  Endocrine disturbances in depression.

Authors:  M A Tichomirowa; M E Keck; H J Schneider; M Paez-Pereda; U Renner; F Holsboer; G K Stalla
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

2.  Vasopressin protects hippocampal neurones in culture against nutrient deprivation or glutamate-induced apoptosis.

Authors:  J Chen; G Aguilera
Journal:  J Neuroendocrinol       Date:  2010-10       Impact factor: 3.627

3.  Repetitive transcranial magnetic stimulation inhibits Sirt1/MAO-A signaling in the prefrontal cortex in a rat model of depression and cortex-derived astrocytes.

Authors:  Zheng-Wu Peng; Fen Xue; Cui-Hong Zhou; Rui-Guo Zhang; Ying Wang; Ling Liu; Han-Fei Sang; Hua-Ning Wang; Qing-Rong Tan
Journal:  Mol Cell Biochem       Date:  2017-09-25       Impact factor: 3.396

Review 4.  Rehabilitating the addicted brain with transcranial magnetic stimulation.

Authors:  Marco Diana; Tommi Raij; Miriam Melis; Aapo Nummenmaa; Lorenzo Leggio; Antonello Bonci
Journal:  Nat Rev Neurosci       Date:  2017-09-29       Impact factor: 34.870

Review 5.  [Transcranial magnetic stimulation (TMS) in basic and clinical neuroscience research].

Authors:  A Valero-Cabré; A Pascual-Leone; O A Coubard
Journal:  Rev Neurol (Paris)       Date:  2011-03-21       Impact factor: 2.607

Review 6.  Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research.

Authors:  Simone Rossi; Mark Hallett; Paolo M Rossini; Alvaro Pascual-Leone
Journal:  Clin Neurophysiol       Date:  2009-10-14       Impact factor: 3.708

7.  Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy; Ramy Moharram; Irina Velicu; Brian M Martin
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

Review 8.  Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression?

Authors:  Frank Padberg; Hans-Jürgen Möller
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex.

Authors:  Sang Soo Cho; Antonio P Strafella
Journal:  PLoS One       Date:  2009-08-21       Impact factor: 3.240

Review 10.  Neurostimulatory and ablative treatment options in major depressive disorder: a systematic review.

Authors:  Pablo Andrade; Lieke H M Noblesse; Yasin Temel; Linda Ackermans; Lee W Lim; Harry W M Steinbusch; Veerle Visser-Vandewalle
Journal:  Acta Neurochir (Wien)       Date:  2010-01-26       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.